论文部分内容阅读
目的分析曲美他嗪联合阿托伐他汀钙治疗冠心病心绞痛(CHD)的临床效果。方法选取2015年1月-2017年1月东莞市虎门医院心内科收治的CHD患者68例作为研究对象,将其随机分为联合组和对照组各34例。对照组在常规治疗基础上加服曲美他嗪,联合组在对照组治疗基础上加服阿托伐他汀钙,比较两组的临床治疗效果。结果治疗后联合组血脂水平均优于对照组,组间差异有统计学意义(P<0.05);联合组治疗总有效率为94.1%,显著高于对照组的73.5%,差异有统计学意义(P<0.05)。结论曲美他嗪联合阿托伐他汀钙治疗CHD疗效显著,对于改善血脂水平、恢复心功能有明显促进作用,值得临床推广。
Objective To analyze the clinical effect of trimetazidine combined with atorvastatin calcium in the treatment of coronary heart disease (CHD). Methods Sixty-eight CHD patients admitted to Department of Cardiology, Humen Hospital, Dongguan City from January 2015 to January 2017 were selected as study subjects, and randomly divided into 34 cases in combination group and control group. In the control group, trimetazidine was added on the basis of routine treatment. At the same time, the combination group was given atorvastatin calcium on the basis of the control group, and the clinical treatment effect was compared between the two groups. Results After treatment, the level of serum lipids in the combination group was better than that in the control group (P <0.05). The total effective rate in the combination group was 94.1%, significantly higher than that in the control group (73.5%), with significant difference (P <0.05). Conclusion Trimetazidine combined with atorvastatin calcium treatment of CHD significant effect on the improvement of blood lipid levels, cardiac function was significantly promoted, worthy of clinical promotion.